You Are Invited To A Private Briefing…

America's First Complete Peptide Ecosystem Is Being Activated!

Here's How Early Investors Can Participate Before Institutional Round Closes...

Quick Points...

- $47 billion market. Zero integrated competitors. We control synthesis, manufacturing, and every distribution channel end-to-end.

- Founder invested $2M. Zero Debt. 80% operational. Revenue generating.

- Three major partnerships locked (in place agreements) - Need inventory capital to activate $10 - $20 Million Revenue.

- Institutional capital closes Q2. This speed round activates instant distribution & revenue from 3 partnerships and receives better investment valuation.

This Is ACTIVATION Capital.

NOT Seed Capital.

Accredited investors only.

$250K minimum.

Speed round closes January 31st.

Request the Confidential Investor Briefing

Inside the private briefing, you will learn...

  • The complete vertical integration no competitor has (synthesis → manufacturing → distribution → platform partnerships)

  • Three locked partnerships ready to activate: 100M+ unit per year supplement platform, social commerce platform (billions of impressions), national foundation (mainstream therapeutic peptide deployment)

  • Behind the scenes walk through of current traction, product lines, proprietary tech, and manufacturing.

  • The seasoned founder with $500million in results who's built, scaled, and exited companies for 20 years - and put $2M of his own capital in this.

  • How you can get equity, owners distributions, or revenue share when you partner with us.

  • End of year tax write off and capital shelter.

Submit the confidential request form.

Leadership team will contact you within 24 hours:

IMPORTANT NOTE: Partnership names and full operational details cannot be disclosed prior to NDA. Complete information provided to verified accredited investors during private briefing.

This site is not a part of the Facebook™ and/or Instagram™. Additionally, This site is NOT endorsed by Facebook™ in any way.

© 2025 Biosyn. All Rights Reserved.